During the past decade, First Health of the Carolinas conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 7 clinical trials were completed, i.e. on average, 53.8% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 4 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "First Health of the Carolinas" #1 sponsor was "Hoffmann-La Roche" with 3 trials, followed by "Bristol-Myers Squibb" with 2 trials sponsored, "EMD Serono Research & Development Institute, Inc." with 2 trials sponsored, "Seagen Inc." with 2 trials sponsored and "Aravive, Inc." with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "First Health of the Carolinas" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator, "Merck Sharp & Dohme LLC" with 2 trials as a collaborator, "Bionomics Limited" with 1 trials as a collaborator, "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 1 trials as a collaborator and "GOG Foundation" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "First Health of the Carolinas" are "Non-Small Cell Lung Cancer" (2 trials), "Breast Cancer" (1 trials), "COPD" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials) and "Colorectal Neoplasms" (1 trials). Many other conditions were trialed in "First Health of the Carolinas" in a lesser frequency.

Most popular intervention types in "First Health of the Carolinas" are "Drug" (12 trials), "Other" (4 trials), "Device" (2 trials), "Biological" (1 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (4 trials), "Paclitaxel" (4 trials), "Placebo" (3 trials), "Bevacizumab" (2 trials) and "Cisplatin" (2 trials). Other intervention names were less common.

The vast majority of trials in "First Health of the Carolinas" are 15 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "First Health of the Carolinas". undefined are not yet recruiting, 5 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in First Health of the Carolinas, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in First Health of the Carolinas, 2 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".